![glp 1 drugs and blood clots Wegovy Lawsuit [2026 Update] Glucagon‐Like Peptide‐1 Receptor Agonists and](https://www.robertkinglawfirm.com/wp-content/uploads/2024/09/does-wegovy-cause-blood-clots.webp)
glp 1 drugs and blood clots Wegovy Lawsuit [2026 Update] Glucagon‐Like Peptide‐1 Receptor Agonists and
Description
In light of this potential significant safety issue, the development of Lotiglipron has been discontinued, meaning the drug did not progress to further clinical trial stages to evaluate its efficacy and safety
![glp 1 drugs and blood clots Wegovy Lawsuit [2026 Update] GlucagonLike Peptide1 Receptor Agonists and](https://www.ahajournals.org/cms/10.1161/JAHA.124.039446/asset/3ed3d6da-a3e2-4c01-a648-48127c98ad79/assets/graphic/jah310873-fig-0005.png)
doi: 10.1007/5584_2020_496 [DOI] [PubMed] [Google Scholar] 143.Hurren KM, Pinelli NR
![glp 1 drugs and blood clots Wegovy Lawsuit [2026 Update] GlucagonLike Peptide1 Receptor Agonists and](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=581525118239605&get_thumbnail=1)
Meanwhile, 35% of Americans said they are interested in trying the drug in the future, according to the consultancy PwC
![glp 1 drugs and blood clots Wegovy Lawsuit [2026 Update] GlucagonLike Peptide1 Receptor Agonists and](https://www.mdpi.com/jcm/jcm-14-06758/article_deploy/html/images/jcm-14-06758-g001-550.jpg)
doi: 10.1111/anae.16306 [DOI] [PubMed] [Google Scholar] 75.Raven LM, Brown C, Greenfield JR
![glp 1 drugs and blood clots Wegovy Lawsuit [2026 Update] GlucagonLike Peptide1 Receptor Agonists and](https://plexusdx.com/cdn/shop/articles/g11_41f29aa9-5fcd-4859-b295-4888034df01d.jpg?v=1781637580&width=2400)
